Ignite Creation Date:
2025-12-24 @ 3:55 PM
Ignite Modification Date:
2025-12-25 @ 2:00 PM
Study NCT ID:
NCT03782792
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2018-12-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-05
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-19
First Submit QC Date:
None
Study First Post Date:
2018-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-22
Results First Submit QC Date:
None
Results First Post Date:
2022-03-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-03-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED